Related Blog Posts
AstraZeneca today announced that the company has s
3 hours ago ago from Pinoy Pharmacy
AstraZeneca today announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.
Related contentDrug Development in the Balance The American, A Magazine of Ideas
7 hours ago ago from Business, Economics, Culture, and More — The American, A Magazine of Ideas
HOME ABOUT US ARCHIVE ADVERTISE CONTACT BLOG RSS FEED SEARCH AMERICAN.COM The Journal of the American Enterprise Institute ARTICLE TOOLS EMAIL A FRIEND EMAIL THE EDITOR PRINT SHARE BLOG COMMENTS Drug Development in the Balance By Jack Calfee Wednesday, December 9, 2009 Filed under: Health & Medicine , Boardroom , Government & Politics , Public Square , World Watch ...
Related contentCongressional Hearing – Prescription Drug Price Inflation: Are Prices Rising Too Fast?
12 hours ago ago from Policy and Medicine
The House Subcommittee on Health (of the House Energy and Commerce Committee) recently held a hearing titled Prescription Drug Price Inflation: Are Prices Rising Too Fast? The purpose of the hearing according to the Subcommittee’s website was to examine recent reports of rapid increases in brand-name prescription drug prices. Witnesses included: Professor Stephen Schondelmeyer , Pharm.D., Ph.D., Professor and Head, Department of ...
Related contentAM FM Headphones
11 hours ago ago from Big News Blog
It is legal to use the Swiss flag for decoration and publicity, but its use is also regulated by the Society for the Promotion of Swiss Products and Services, better known as Swiss Label. A 1931 law, which many now consider a useless relic, prohibits the use of the federal cross on any product not so licensed by the Society. I have ordered several items from Swiss Army Express like the swiss army backpacks and have been pleased with their ...
Related contentIs High Cholesterol a Disease?
13 hours ago ago from Natural Health and Medical Information
No, it is not! But the pharmaceutical industry wants you to believe it is. High cholesterol, such as cancer, diabetes and other conditions of the body are signs that something is wrong internally. Cholesterol is our friend, not the monster that we have painted the medical world in conjunction with the pharmaceutical industry. No Cholesterol life, plain and simple. Cholesterol is vital for optimal functioning of the body in general. ...
Related contentRelated News
CyDex Pharmaceuticals Receives U.S. Patent for New Captisol®
12 hours ago ago from FanHouse
CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol ® technology until 2028. The patent (U.S. Patent No. 7,629,331) ...
Related contentConcert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board
14 hours ago ago from FanHouse
Concert Pharmaceuticals, Inc. announced today the appointment of Lijun Wu, Ph.D., as Vice President, Biology. In this newly created position, Dr. Wu will have responsibility for Concert’s non-clinical pharmacology, pharmacokinetics, drug metabolism, and bioanalytical functions and will report to Roger Tung, Ph.D., President and Chief Executive Officer of Concert. Concert also announced today the addition of Lee Brettman, M.D. and Dennis ...
Related contentAbsorption Systems Appoints Director of Scientific Operations
12 hours ago ago from FanHouse
Absorption Systems , a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today announced that the company has hired Ramesh B. Bambal, Ph.D., as Director of Scientific Operations. Dr. Bambal joins Absorptions Systems with considerable pharmaceutical industry experience in drug discovery and preclinical development. While at Absorption Systems, Dr. Bambal will oversee drug discovery, business ...
Related contentEU raids drug makers in antitrust probe
11 hours ago ago from FanHouse
BRUSSELS -European Union antitrust regulators said they made surprise raids on the offices of drug makers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals. They did not name the companies and said the raids were a preliminary step in an antitrust investigation. If they find the firms guilty, they can fine them up to 10 percent of annual ...
Related contentPerrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
10 hours ago ago from FanHouse
ALLEGAN, Mich., Dec. 9 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has filed an Abbreviated New Drug Application for Clobetasol Propionate Topical Spray, 0.05%, a generic form of Clobex® Spray. Clobex® (clobetasol propionate) spray is indicated for the treatment of moderate to severe plaque psoriasis, and has estimated brand sales at retail of approximately $55 million annually. Perrigo filed its ...
Related content
